Citigroup has recently reduced Illumina Inc (ILMN) stock to Neutral rating, as announced on December 11, 2024, according to Finviz. Earlier, on November 12, 2024, Morgan Stanley had resumed the stock ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Illumina (ILMN), which belongs to the Zacks ...

Illumina, Inc. ILMN has announced a collaboration with NVIDIA NVDA to advance technology platforms for analyzing and interpreting multiomic data. By combining advancements in artificial intelligence ...

Leerink Partners analyst Puneet Souda has maintained their bullish stance on ILMN stock, giving a Buy rating on January 10.Stay Ahead of the ...

Genomics is becoming the future of medicine as technological advancements continue to unlock our DNA’s vast potential. Given ...

Buying $100 In ILMN: If an investor had bought $100 of ILMN stock 20 years ago, it would be worth $3,290.99 today based on a ...

In a report released today, Tejas Savant from Morgan Stanley maintained a Hold rating on Illumina (ILMN – Research Report), with a price target ...

Stock analysts at Leerink Partnrs decreased their Q4 2025 earnings per share (EPS) estimates for Illumina in a note issued to ...

Failed to fetch dynamically imported module: https://ca.finance.yahoo.com/assets/_app/immutable/nodes/30.B22WYnlf.js ...

It is worth considering Illumina (ILMN), which belongs to the Zacks Medical - Biomedical and Genetics industry. When looking at the last two reports, this genetic testing tools company has ...